{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:11:24Z","timestamp":1788307884839,"version":"build-2803163510"},"reference-count":15,"publisher":"Centers for Disease Control MMWR Office","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6905a5","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T10:02:47Z","timestamp":1580983367000},"page":"136-139","source":"Crossref","is-referenced-by-count":22,"title":["Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, <i>Haemophilus influenzae<\/i> Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants"],"prefix":"10.15585","volume":"69","author":[{"given":"Sara E.","family":"Oliver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R1","unstructured":"Food and Drug Administration. Vaxelis (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, Haemophilus b conjugate [meningococcal protein conjugate] and Hepatitis B [recombinant] vaccine). [Package insert]. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2018. https:\/\/www.fda.gov\/media\/119465\/download"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ypmed.2004.12.001","article-title":"Do too many shots due lead to missed vaccination opportunities? Does it matter?","volume":"41","author":"Meyerhoff","year":"2005","journal-title":"Prev Med"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","article-title":"Use of combination vaccines is associated with improved coverage rates.","volume":"26","author":"Marshall","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R4","unstructured":"Ezeanolue E, Harriman K, Hunter P, Kroger A, Pellegrini C. General best practice guidelines for immunization. Best practice guidance of the Advisory Committee on Immunization Practices (ACIP). Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/index.html"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R5","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1542\/peds.2014-4102","article-title":"Immunogenicity, safety and tolerability of a hexavalent vaccine in infants.","volume":"136","author":"Marshall","year":"2015","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/INF.0000000000001405","article-title":"Lot-to-lot consistency, safety, tolerability and immunogenicity of an investigational hexavalent vaccine in U.S. infants.","volume":"36","author":"Block","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/INF.0000000000001406","article-title":"A phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at two, three, four and twelve months.","volume":"36","author":"Vesikari","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R8","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1016\/j.vaccine.2016.05.054","article-title":"A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months.","volume":"34","author":"Silfverdal","year":"2016","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R9","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1016\/j.vaccine.2017.05.043","article-title":"Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).","volume":"35","author":"Martin\u00f3n-Torres","year":"2017","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R10","unstructured":"MCM Vaccines B.V. Immunogenicity and safety of V419 (PR51) in combination with MCC in infants and toddlers (V419\u2013011). Identifier NCT01553279. Washington, DC: US National Library of Medicine; 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01553279"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/INF.0000000000000849","article-title":"Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia.","volume":"34","author":"Desai","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R12","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus and diphtheria with vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R13","first-page":"829","article-title":"Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.","volume":"58","author":"CDC","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R14","article-title":"Prevention and control of Haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP).","volume":"63","author":"Briere","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.mm6905a5-202002061002-R15","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T10:02:50Z","timestamp":1580983370000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6905a5.htm?s_cid=mm6905a5_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,2,7]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6905a5","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2,7]]},"published":{"date-parts":[[2020,2,7]]}}}